First Line gastroeSOphageal metastatiC canceR primAry and disTant (if Oligometastatic) lEsions-directed Radiotherapy, a Multicentric, Phase III, Randomized Controlled Trial

NCT06922279 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

108

Enrollment

OTHER

Sponsor class

Conditions

Gastroesophageal Cancer (GC)

Interventions

RADIATION: Radiation Therapy + standard sistemic therapy (chemoteraphy)
DRUG: Standard systemic therapy (chemotherapy)

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS